ACNB (NASDAQ:ACNB) Stock, Quote.Headers.trade-ideas

ACNB

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Bank which generates the majority of the revenue provides banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

Earnings

News

Penny Stocks

Eurozone

Commodities

Global

Intraday Update

Markets

FFHL

NCMI

VUZI

Toward the end of trading Friday, the Dow traded down 0.18% to 28,241 while the NASDAQ fell 1.18% to 11,322.57. The S&amp;P also fell, dropping 1.16% to 3414.86.

Mid-Afternoon Market Update: US Stocks Pare Losses; Dow Down 50 Points

Movers

Trading Ideas

AAOI

AAON

AAWW

ABCB

ABEV

ABMD

ABTX

ACBI

ACCO

ACEL

ACGL

ACHC

ACIW

ACRE

ACRX

ADES

ADMA

ADMS

ADPT

ADTN

AERI

AFGC

AFIN

AFMD

AFYA

AGCO

AGLE

AGNC

AGRO

AIMC

AIMT

AINV

AKCA

AKRX

AKTS

ALBO

ALDX

ALEX

ALGT

ALKS

ALLY

ALRM

ALRS

Stocks That Hit 52-Week Lows On Thursday

AAEEF

AAVMY

ABGSF

ACCFF

ACCYY

ACHV

ACRFF

ACRGF

ACSAY

ACST

ACTG

ADVZF

AFLYY

AGEEF

AGESY

AGLXY

AHFD

AHKSY

AHOTF

AICAF

AIPUY

AIRG

AIRYY

AISSF

AKO-A

AKZOY

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ALOT

ALSN

ALTM

ALXEF

ALXN

AMCR

AMHPF

AMKBF

AMKBY

AMNB

AMPH

AMRN

AMSLF

ANAT

ANGO

ANIP

Australia and New Zealand Banking Group Limited

ANZBY

ANZFF

APELY

APEX

APHA

APTS

ARCB

ARCC

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARRRF

Stocks That Hit 52-Week Lows On Friday

ACNB Corp

Hovde Group analyst David Bishop upgrades ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) from Market Perform to Outperform.

Upgrades

Analyst Ratings

Hovde Group Upgrades ACNB to Outperform

Piper Sandler analyst Justin Crowley maintains ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) with a Neutral and lowers the price target from $40 to $37.

Price Target

Piper Sandler Maintains Neutral on ACNB, Lowers Price Target to $37

ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) reported quarterly earnings of $0.80 per share which met the analyst consensus estimate.

ACNB Q1 2024 GAAP EPS $0.80, Inline

ACNB Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced today that the Board of Directors approved and declared a regular quarterly cash dividend of $0.32 per share of ACNB Corporation common stock payable on June 14, 2024, to shareholders of record as of May 31, 2024. This per share amount reflects a 14.2% increase over the $0.28 per share paid in the second quarter of 2023, and a 6.6% increase over the $0.30 per share paid in the first quarter of 2024. This dividend declaration will result in aggregate dividend payments of approximately $2.72 million to ACNB Corporation shareholders in the second quarter of 2024. &nbsp;
"I am pleased to announce this increase in ACNB Corporation's quarterly dividend, which reflects our Board of Directors' longstanding commitment to delivering value to shareholders in the form of quarterly cash dividend payments," said James P. Helt, ACNB Corporation President &amp; Chief Executive Officer. Mr. Helt continued, "Our decision to increase the dividend is a testament to the strength of our financial position and our confidence in the future growth and profitability of ACNB Corporation. This dividend declaration also represents our second increase to the quarterly cash dividend in less than a year, and represents the fourth consecutive calendar year the Corporation has increased the quarterly cash dividend."

Dividends

ACNB Corporation Announces Increase In Quarterly Cash Dividend From $0.30 To $0.32 Per Share

Offerings

ACNB Corp Files For Mixed Shelf Of Upto $100M

WIIM

DCOM

FIBK

FITB

HIFS

HTLF

IBTX

INDB

PPBI

SFNC

SMBC

UCBI

Shares of banking companies are trading lower amid overall market weakness after the Federal Reserve left rates unchanged.

ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) reported quarterly earnings of $0.48 per share. This is a 60 percent decrease over earnings of $1.20 per share from the same period last year.

ACNB Q4 EPS $0.48 Down From $1.20 YoY

Piper Sandler analyst Justin Crowley maintains ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) with a Neutral and raises the price target from $43 to $49.

Piper Sandler Maintains Neutral on ACNB, Raises Price Target to $49

Piper Sandler analyst Justin Crowley maintains ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) with a Neutral and raises the price target from $35 to $37.

Piper Sandler Maintains Neutral on ACNB, Raises Price Target to $37

ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) reported quarterly earnings of $1.06 per share which beat the analyst consensus estimate of $0.99 by 7.07 percent. This is a 11.67 percent decrease over earnings of $1.20 per share from the same period last year.

ACNB Q3 EPS $1.06 Beats $0.99 Estimate

ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.02 by 9.8 percent. This is a 13.13 percent increase over earnings of $0.99 per share from the same period last year.

Earnings Beats

ACNB Q2 EPS $1.12 Beats $1.02 Estimate

AROW

CUBI

CVBF

CZNC

FFBC

FFIC

FFWM

FGBI

FRBK

FULT

MYFW

PACW

ROOT

SMMF

TRUP

UBSI

WSFS

Shares of banks and financial services stocks are trading higher. Strength may be due to a rotation out of tech names and an overall sector rebound following banking concerns earlier in the year.

<h3>Upgrades</h3>
For The Carlyle Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>), Raymond James upgraded the previous rating of Market Perform to Outperform. For the first quarter, Carlyle Group had an EPS of $0.63, compared to year-ago quarter EPS of $0.74. The stock has a 52-week-high of $40.73 and a 52-week-low of $24.61. At the end of the last trading period, Carlyle Group closed at $28.15. 
Piper Sandler upgraded the previous rating for Akebia Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>) from Neutral to Overweight. In the first quarter, Akebia Therapeutics showed an EPS of $0.14, compared to $0.35 from the year-ago quarter. The current stock performance of Akebia Therapeutics shows a 52-week-high of $1.63 and a 52-week-low of $0.24. Moreover, at the end of the last trading period, the closing price was at $0.96. 
According to BTIG, the prior rating for Q2 Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) was changed from Neutral to Buy. For the first quarter, Q2 Holdings had an EPS of $0.35, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $55.26 and a 52-week-low of $18.91. At the end of the last trading period, Q2 Holdings closed at $27.65. 
For Avis Budget Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>), Deutsche Bank upgraded the previous rating of Hold to Buy. Avis Budget Gr earned $7.72 in the first quarter, compared to $9.99 in the year-ago quarter. At the moment, the stock has a 52-week-high of $251.26 and a 52-week-low of $131.85. Avis Budget Gr closed at $163.27 at the end of the last trading period. 
According to Baird, the prior rating for Xylem Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) was changed from Neutral to Outperform. Xylem earned $0.72 in the first quarter, compared to $0.47 in the year-ago quarter. At the moment, the stock has a 52-week-high of $118.58 and a 52-week-low of $72.13. Xylem closed at $98.59 at the end of the last trading period. 
For Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), JP Morgan upgraded the previous rating of Underweight to Neutral. In the first quarter, Chevron showed an EPS of $3.55, compared to $3.36 from the year-ago quarter. The current stock performance of Chevron shows a 52-week-high of $189.66 and a 52-week-low of $132.54. Moreover, at the end of the last trading period, the closing price was at $153.12. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
<h3>Downgrades</h3>
For GreenLight Biosciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRNA#NASDAQ">GRNA</a>), Canaccord Genuity downgraded the previous rating of Buy to Hold. GreenLight Biosciences earned $0.19 in the first quarter, compared to $0.34 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.34 and a 52-week-low of $0.18. GreenLight Biosciences closed at $0.29 at the end of the last trading period. 
According to Seaport Global, the prior rating for PDC Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDCE#NASDAQ">PDCE</a>) was changed from Buy to Neutral. PDC Energy earned $2.61 in the first quarter, compared to $3.66 in the year-ago quarter. The stock has a 52-week-high of $89.20 and a 52-week-low of $51.72. At the end of the last trading period, PDC Energy closed at $69.87. 
Keybanc downgraded the previous rating for Ambarella Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) from Overweight to Sector Weight. For the first quarter, Ambarella had an EPS of $0.15, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $99.86 and a 52-week-low of $49.02. At the end of the last trading period, Ambarella closed at $81.96. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
<h3>Initiations</h3>
TD Cowen initiated coverage on MDxHealth SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXH#NASDAQ">MDXH</a>) with an Outperform rating. The price target for MDxHealth is set to $7.00. In the first quarter, MDxHealth showed an EPS of $0.05, compared to $0.05 from the year-ago quarter. 
William Blair initiated coverage on PROCEPT BioRobotics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCT#NASDAQ">PRCT</a>) with an Outperform rating. In the first quarter, PROCEPT BioRobotics showed an EPS of $0.63, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $52.40 and a 52-week-low of $25.29. PROCEPT BioRobotics closed at $31.40 at the end of the last trading period. 
With an Outperform rating, Noble Capital Markets initiated coverage on Saga Communications Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGA#NASDAQ">SGA</a>). The price target seems to have been set at $27.00 for Saga Communications. Saga Communications earned $0.15 in the first quarter, compared to $0.20 in the year-ago quarter. 
Hovde Group initiated coverage on ACNB Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) with an Outperform rating. The price target for ACNB is set to $36.00. In the first quarter, ACNB showed an EPS of $1.06, compared to $0.76 from the year-ago quarter. The stock has a 52-week-high of $41.17 and a 52-week-low of $27.00. At the end of the last trading period, ACNB closed at $30.32. 
Northland Capital Markets initiated coverage on Near Intelligence Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIR#NASDAQ">NIR</a>) with an Outperform rating. The price target for Near Intelligence is set to $8.00. In the first quarter, Near Intelligence showed an EPS of $1.20, compared to $0.49 from the year-ago quarter. The current stock performance of Near Intelligence shows a 52-week-high of $18.65 and a 52-week-low of $1.55. Moreover, at the end of the last trading period, the closing price was at $1.80. 
For BRC Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>), Needham initiated coverage, by setting the current rating at Hold. BRC earned $0.08 in the first quarter, compared to $1.36 in the year-ago quarter. The current stock performance of BRC shows a 52-week-high of $11.04 and a 52-week-low of $4.79. Moreover, at the end of the last trading period, the closing price was at $5.63. 
UBS initiated coverage on argenx SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) with a Buy rating. The price target for argenx is set to $480.00. In the first quarter, argenx showed an EPS of $0.52, compared to $4.36 from the year-ago quarter. The stock has a 52-week-high of $423.99 and a 52-week-low of $304.94. At the end of the last trading period, argenx closed at $392.36. 
RBC Capital initiated coverage on Colliers International Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIGI#NASDAQ">CIGI</a>) with an Outperform rating. The price target for Colliers Intl Gr is set to $128.00. For the first quarter, Colliers Intl Gr had an EPS of $0.86, compared to year-ago quarter EPS of $1.44. The current stock performance of Colliers Intl Gr shows a 52-week-high of $133.03 and a 52-week-low of $84.16. Moreover, at the end of the last trading period, the closing price was at $93.16. 
With a Buy rating, Goldman Sachs initiated coverage on Cedar Fair LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUN#NYSE">FUN</a>). The price target seems to have been set at $50.00 for Cedar Fair. In the first quarter, Cedar Fair showed an EPS of $2.61, compared to $1.56 from the year-ago quarter. The current stock performance of Cedar Fair shows a 52-week-high of $49.36 and a 52-week-low of $37.92. Moreover, at the end of the last trading period, the closing price was at $44.17. 
Goldman Sachs initiated coverage on SeaWorld Entertainment Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEAS#NYSE">SEAS</a>) with a Buy rating. The price target for SeaWorld Entertainment is set to $75.00. SeaWorld Entertainment earned $0.26 in the first quarter, compared to $0.12 in the year-ago quarter. The stock has a 52-week-high of $68.19 and a 52-week-low of $40.02. At the end of the last trading period, SeaWorld Entertainment closed at $56.00. 
Needham initiated coverage on Sovos Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOVO#NASDAQ">SOVO</a>) with a Buy rating. The price target for Sovos Brands is set to $22.50. In the first quarter, Sovos Brands showed an EPS of $0.18, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $20.58 and a 52-week-low of $12.50. At the end of the last trading period, Sovos Brands closed at $18.48. 
With a Sell rating, Goldman Sachs initiated coverage on Six Flags Entertainment Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIX#NYSE">SIX</a>). The price target seems to have been set at $26.00 for Six Flags Entertainment. Six Flags Entertainment earned $0.84 in the first quarter, compared to $0.76 in the year-ago quarter. The current stock performance of Six Flags Entertainment shows a 52-week-high of $31.29 and a 52-week-low of $16.83. Moreover, at the end of the last trading period, the closing price was at $25.48. 
With a Buy rating, Goldman Sachs initiated coverage on Telefonica Brasil SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIV#NYSE">VIV</a>). The price target seems to have been set at $10.00 for Telefonica Brasil. For the fourth quarter, Telefonica Brasil had an EPS of $0.13, compared to year-ago quarter EPS of $0.28. The stock has a 52-week-high of $11.03 and a 52-week-low of $6.49. At the end of the last trading period, Telefonica Brasil closed at $8.12. 
William Blair initiated coverage on Qualys Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) with an Outperform rating. For the first quarter, Qualys had an EPS of $1.09, compared to year-ago quarter EPS of $0.89. The stock has a 52-week-high of $162.36 and a 52-week-low of $101.10. At the end of the last trading period, Qualys closed at $122.91. 
With an Outperform rating, RBC Capital initiated coverage on Nevro Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVRO#NYSE">NVRO</a>). The price target seems to have been set at $40.00 for Nevro. In the first quarter, Nevro showed an EPS of $0.98, compared to $0.98 from the year-ago quarter. The current stock performance of Nevro shows a 52-week-high of $53.22 and a 52-week-low of $25.82. Moreover, at the end of the last trading period, the closing price was at $26.04. 
With a Neutral rating, Goldman Sachs initiated coverage on TIM SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIMB#NYSE">TIMB</a>). The price target seems to have been set at $15.00 for TIM. At the moment, the stock has a 52-week-high of $15.27 and a 52-week-low of $10.20. TIM closed at $14.27 at the end of the last trading period. 
Goldman Sachs initiated coverage on America Movil SAB de CV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMX#NYSE">AMX</a>) with a Neutral rating. The price target for America Movil is set to $24.00. In the first quarter, America Movil showed an EPS of $0.51, compared to $0.47 from the year-ago quarter. The stock has a 52-week-high of $23.07 and a 52-week-low of $15.68. At the end of the last trading period, America Movil closed at $21.99. 
Goldman Sachs initiated coverage on Liberty Latin America Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILA#NASDAQ">LILA</a>) with a Buy rating. The price target for Liberty Latin America is set to $10.00. For the first quarter, Liberty Latin America had an EPS of $0.23, compared to year-ago quarter EPS of $0.36. The current stock performance of Liberty Latin America shows a 52-week-high of $10.01 and a 52-week-low of $5.90. Moreover, at the end of the last trading period, the closing price was at $7.29. 
With a Buy rating, Goldman Sachs initiated coverage on Grupo Televisa SAB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TV#NYSE">TV</a>). The price target seems to have been set at $6.10 for Grupo Televisa. For the first quarter, Grupo Televisa had an EPS of $0.07, compared to year-ago quarter EPS of $0.18. The current stock performance of Grupo Televisa shows a 52-week-high of $10.39 and a 52-week-low of $4.38. Moreover, at the end of the last trading period, the closing price was at $4.76. 
With a Buy rating, Roth MKM initiated coverage on ASLAN Pharmaceuticals Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASLN#NASDAQ">ASLN</a>). The price target seems to have been set at $15.00 for ASLAN Pharma. For the first quarter, ASLAN Pharma had an EPS of $1.29, compared to year-ago quarter EPS of $0.95. The current stock performance of ASLAN Pharma shows a 52-week-high of $4.93 and a 52-week-low of $1.70. Moreover, at the end of the last trading period, the closing price was at $3.72. 
Roth MKM initiated coverage on Inventiva SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) with a Buy rating. The price target for Inventiva is set to $11.00. None 
With a Buy rating, Roth MKM initiated coverage on Terns Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TERN#NASDAQ">TERN</a>). The price target seems to have been set at $23.00 for Terns Pharma. In the first quarter, Terns Pharma showed an EPS of $0.31, compared to $0.55 from the year-ago quarter. The current stock performance of Terns Pharma shows a 52-week-high of $14.04 and a 52-week-low of $1.53. Moreover, at the end of the last trading period, the closing price was at $10.56. 
With a Buy rating, Roth MKM initiated coverage on Unity Biotechnology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBX#NASDAQ">UBX</a>). The price target seems to have been set at $10.00 for Unity Biotechnology. For the first quarter, Unity Biotechnology had an EPS of $0.76, compared to year-ago quarter EPS of $2.80. The current stock performance of Unity Biotechnology shows a 52-week-high of $18.50 and a 52-week-low of $1.46. Moreover, at the end of the last trading period, the closing price was at $2.93. 
With a Neutral rating, DA Davidson initiated coverage on MasterCraft Boat Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCFT#NASDAQ">MCFT</a>). The price target seems to have been set at $29.00 for MasterCraft Boat Hldgs. For the third quarter, MasterCraft Boat Hldgs had an EPS of $1.36, compared to year-ago quarter EPS of $1.36. The current stock performance of MasterCraft Boat Hldgs shows a 52-week-high of $35.29 and a 52-week-low of $18.49. Moreover, at the end of the last trading period, the closing price was at $26.71. 
With a Buy rating, Mizuho initiated coverage on NICE Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NICE#NASDAQ">NICE</a>). The price target seems to have been set at $244.00 for NICE. For the first quarter, NICE had an EPS of $2.03, compared to year-ago quarter EPS of $1.80. The current stock performance of NICE shows a 52-week-high of $235.05 and a 52-week-low of $164.86. Moreover, at the end of the last trading period, the closing price was at $196.57. 
Mizuho initiated coverage on Five9 Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>) with a Buy rating. The price target for Five9 is set to $100.00. For the first quarter, Five9 had an EPS of $0.41, compared to year-ago quarter EPS of $0.22. At the moment, the stock has a 52-week-high of $120.29 and a 52-week-low of $46.63. Five9 closed at $60.88 at the end of the last trading period. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

ACNB

ACNB (ACNB) Forecast

ACNB (NASDAQ:ACNB) Stock, Quote.Headers.trade-ideas